Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
about
Mouse xenograft models vs GEM models for human cancer therapeuticsMurine models to evaluate novel and conventional therapeutic strategies for cancerAlpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinomaAnimal Models of Uveal Melanoma: Methods, Applicability, and LimitationsCurrent State of Animal (Mouse) Modeling in Melanoma ResearchMolecular and clinical implementations of ovarian cancer mouse avatar modelsHooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic eraNonlinear optical microscopy for histology of fresh normal and cancerous pancreatic tissuesOvine pulmonary adenocarcinoma: a large animal model for human lung cancerDevelopment and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaThe synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinomaA synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation modelA better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivoDevelopment and characterization of xenograft model systems for adenoid cystic carcinoma.Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE)The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Guidelines for the welfare and use of animals in cancer research.Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.Experimental models of hepatocellular carcinomaThe progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy.Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.Hepatocellular carcinoma: insight from animal models.An immunocompetent, orthotopic mouse model of epithelial ovarian cancer utilizing tissue engineered tumor cell sheetsPrediction of individual response to anticancer therapy: historical and future perspectivesAnticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823A deletion in FOXN1 is associated with a syndrome characterized by congenital hypotrichosis and short life expectancy in Birman cats.Tumor microenvironment: a new treatment target for cancerOncolytic vaccinia virus therapy of salivary gland carcinomaIdentification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.The promise and challenge of ovarian cancer models.Human tumor xenografts: the good, the bad, and the ugly.Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma.Chemical approaches to the discovery and development of cancer therapies.Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.Patient-derived cell models as preclinical tools for genome-directed targeted therapy.What do, can and should we learn from models to evaluate potential anticancer agents?Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: a human tumor model in pigs.A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro.
P2860
Q24657555-BF6EDAAA-BFB3-452F-967D-CA1F3A9BEA57Q24673595-3A8D407B-3677-4BB9-8C59-5D7B9C64509FQ26741197-02A4D703-9698-435C-9296-8BFDB32D91DEQ26745595-3E5CFC56-3E9F-4039-804A-0CD2003C5D02Q26781652-6E67E315-B1C7-4C0B-9FC8-11E19B394945Q26786724-B3544329-9537-4587-ACE1-16F98B486199Q27024966-F184385C-0D19-40E3-AF94-B7E310B4338BQ27302067-62376E23-57D1-4EED-A41A-6CA20E1F363FQ28088774-987BE3C0-6A13-4303-A8AD-A852A60BE01EQ28534618-9B0A5008-C352-40AC-A5BD-6A6C4B575305Q28538702-18F50545-3C18-4448-AF86-6B26F54A4D2AQ28538737-F495E770-E124-46E9-B069-BE8905CF1545Q28546961-4AF99270-06DA-4A0B-9248-2FBF006D2FA5Q30410903-66B82266-9164-4A6C-BBA6-9FE86D00A3EFQ30423597-F8F5A1BE-D938-43CA-8E83-0C265FB439F2Q30557217-D420C890-4F79-4B96-9DA5-9114F36D8B01Q33815087-733B5C7F-75EC-4012-BB83-923E4EC3F9E4Q33903753-957D1635-A642-49C3-A3B3-084519873CCDQ34099183-5C297BC0-4FCA-4F37-88B7-4A69533EABD4Q34345987-CD178478-64BC-4A17-B580-14ED860FE2B2Q34488368-8C483C47-BDCE-40B7-B213-FD4254D7652FQ34628001-8C0F4F45-DD44-4254-BB81-6C4768B7979FQ34633249-0ACFEDC8-A92C-4DE5-B13C-8F4BC28F03E9Q34919480-CD7389E5-D60D-4D30-ACF8-803A728AD9EBQ35024682-AE300EE9-5B88-4BC1-8A2D-B2F7BD0E2234Q35045429-B6117573-BF64-4FD3-B4BE-09AEF008F123Q35186574-AB44244D-93FC-4CF5-A903-2C47EA5DEFC7Q35361431-0A823EAB-CCEA-4122-BC76-5D1A0299B06FQ35549696-E0E01157-E46A-44DF-BCCE-99C6779EBC37Q35754885-EC1C46B8-3832-441A-8A2A-26BCFA06AD7CQ35771750-3DF2F959-B5A4-462E-AFCD-5002C34F37BAQ35939496-F2D7BBA5-CC90-45B2-AA0A-E36F4755CA24Q36004070-1FA7A3F4-5CD2-46EA-818C-37BD6D9084CDQ36085630-7EB40F2F-B81B-49A7-AB72-21E3E663FEC1Q36248532-4651BE42-EC8D-40ED-8746-2A8677AE3680Q36413247-43DF4FDA-A17D-4A84-ACFF-16A602721D60Q36430731-1E2F75E9-E554-48F1-A57F-5419C66DF150Q36485336-00F1DB6D-8A78-4EE2-9B5F-6DD2FB154DB1Q36574540-E9E2F4C4-1843-4A2C-B4C8-9E73AAB1A391Q36642760-002BC917-99CA-43BF-B843-70F03BFE5C0B
P2860
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Of mice and men: values and li ...... n anticancer drug development.
@ast
Of mice and men: values and li ...... n anticancer drug development.
@en
type
label
Of mice and men: values and li ...... n anticancer drug development.
@ast
Of mice and men: values and li ...... n anticancer drug development.
@en
prefLabel
Of mice and men: values and li ...... n anticancer drug development.
@ast
Of mice and men: values and li ...... n anticancer drug development.
@en
P1476
Of mice and men: values and li ...... n anticancer drug development.
@en
P2093
Kelland LR
P304
P356
10.1016/J.EJCA.2003.11.028
P577
2004-04-01T00:00:00Z